These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7455025)

  • 21. [Results of fractionation optimization of tumours of the bladder in homogeneous patient collectives (author's transl)].
    Kob D; Arndt J; Albert L; Kriester A; Herrmann S
    Radiobiol Radiother (Berl); 1980; 21(6):738-42. PubMed ID: 7244167
    [No Abstract]   [Full Text] [Related]  

  • 22. Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy.
    Cowan RA; McBain CA; Ryder WD; Wylie JP; Logue JP; Turner SL; Van der Voet J; Collins CD; Khoo VS; Read GR
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):197-207. PubMed ID: 15093917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of bladder-conserving treatment, consisting of brachytherapy combined with limited surgery and external beam radiotherapy, for patients with solitary T1-T3 bladder tumors less than 5 cm in diameter.
    Blank LE; Koedooder K; van Os R; van de Kar M; van der Veen JH; Koning CC
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):454-8. PubMed ID: 17560734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Change of the coefficient of dosage irregularity in fractionated gamma therapy with the use of grid diaphragms].
    Aliev BM; Galina LS
    Med Radiol (Mosk); 1976 Jan; 21(1):68-71. PubMed ID: 933738
    [No Abstract]   [Full Text] [Related]  

  • 25. Organ-sparing treatment in muscle-invasive bladder cancer.
    Dunst J; Diestelhorst A; Kühn R; Müller AC; Scholz HJ; Fornara P
    Strahlenther Onkol; 2005 Oct; 181(10):632-7. PubMed ID: 16220401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretreatment proliferation and local control in bladder cancer after radiotherapy with or without concurrent chemotherapy.
    Weiss C; Rödel F; Ott O; Engehausen DG; Papadopoulos T; Sauer R; Rödel C
    Strahlenther Onkol; 2007 Oct; 183(10):552-6. PubMed ID: 17896086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
    Søndergaard J; Høyer M; Petersen JB; Wright P; Grau C; Muren LP
    Acta Oncol; 2009; 48(2):238-44. PubMed ID: 18759144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radical radiotherapy for urinary bladder cancer: treatment outcomes.
    Fokdal L; Høyer M; von der Maase H
    Expert Rev Anticancer Ther; 2006 Feb; 6(2):269-79. PubMed ID: 16445379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [BCG and radiotherapy: the compatibility of 2 conservative treatments for cancer of the urinary bladder].
    Sánchez-Martín FM; Palou Redorta J; Regalado Pareja R; Rubio Briones J; Villavicencio Mavric H; Vicente Rodríguez J
    Arch Esp Urol; 1999 Sep; 52(7):749-58. PubMed ID: 10540765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Complications of radiotherapy for invasive bladder cancer: acute and chronic effects. Method of evaluation: measurement by RTOG/EORTC, SOMA/LENT].
    Esco Barón R; Baquedano Baquedano JE
    Arch Esp Urol; 1999; 52(6):675-83. PubMed ID: 10484851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide.
    Hoskin PJ; Saunders MI; Dische S
    Cancer; 1999 Oct; 86(7):1322-8. PubMed ID: 10506720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Conservative treatment of infiltrating cancer of the bladder: neoadjuvant chemotherapy and radiotherapy].
    Prié L; Gaston R; Ferrière JM; Richaud P; Bui BN; Guillou ML
    Cancer Radiother; 1998 Apr; 2 Suppl 1():62s-66s. PubMed ID: 9749081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bladder-sparing therapy for muscle-infiltrating bladder cancer.
    Pansadoro V; Emiliozzi P
    Nat Clin Pract Urol; 2008 Jul; 5(7):368-75. PubMed ID: 18560383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linear and parametric programming applied to radiation treatment planning.
    Bahr GK; Kereiakes JG; Horwitz H; Compaan P; Holt JG; Goode K
    Rev Paul Med; 1969 Aug; 75(2):210. PubMed ID: 5374088
    [No Abstract]   [Full Text] [Related]  

  • 35. Hyperbaric oxygen and radiotherapy.
    McEwen JB
    Arq Patol; 1968 Apr; 40(1):49-54. PubMed ID: 5712965
    [No Abstract]   [Full Text] [Related]  

  • 36. Combined chemotherapy and irradiation for transitional cell cancer of the bladder: a review.
    Beuzeboc P; Pontvert D; Pouillart P; Cosset JM
    J Infus Chemother; 1995; 5(4):218-20. PubMed ID: 8934733
    [No Abstract]   [Full Text] [Related]  

  • 37. [Radiotherapy of bladder tumors].
    Swyngedauw J
    Acta Urol Belg; 1971 Jan; 39(1):24-7. PubMed ID: 5581466
    [No Abstract]   [Full Text] [Related]  

  • 38. [Palliative radiotherapy of bladder cancer].
    Errazquin Sáenz de Tejada L; González Ferreira JA; Mesa Sáenz CM; Sánchez Calzado JA; Hebrero Jiménez ML
    Arch Esp Urol; 1999; 52(6):627-36. PubMed ID: 10484846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term results of primary adenocarcinoma of the urinary bladder: a report on 192 patients.
    Zaghloul MS; Nouh A; Nazmy M; Ramzy S; Zaghloul AS; Sedira MA; Khalil E
    Urol Oncol; 2006; 24(1):13-20. PubMed ID: 16414487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cisplatin and radiotherapy: towards a new therapeutic system?].
    Reboul F; Vincent P; Serin D; Alfonsi M; Plat F
    Bull Cancer Radiother; 1990; 77(2):95-100. PubMed ID: 8703552
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.